Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Bosch

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|September 17, 2004
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomideClara Montagut, Francesc Bosch, Luís Villela, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
Gene expression profiling in chronic lymphocytic leukaemiaCarles Codony, Marta Crespo, Pau Abrisqueta, et al.
Gastroenterologia Y Hepatologia|April 19, 2015
[Importance of hepatitis B virus screening in hematological patients]Mar Riveiro-Barciela, Gonzalo Artaza, Pau Abrisqueta, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 4, 2019
Acquired von Willebrand syndrome in a patient with small lymphocytic lymphoma and Sjögren's syndrome: which associated condition should be prioritized?José Pardos-Gea, Fernanda Martínez, Pau Abrisqueta, et al.
Experimental Hematology|December 29, 2016
Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effectGuillermo Orti, Pere Barba, Laura Fox, et al.
Haematologica|March 17, 2004
Familial lymphoid neoplasms in patients with mantle cell lymphomaFrederic Tort, Emma Camacho, Francesc Bosch, et al.
Blood|October 6, 2005
How I treat refractory CLLEmili Montserrat, Carol Moreno, Jordi Esteve, et al.
Oncotarget|December 30, 2014
Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivoNoelia Purroy, Pau Abrisqueta, Júlia Carabia, et al.
Haematologica|December 16, 2017
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvementSabela Bobillo, Pau Abrisqueta, Cecilia Carpio, et al.
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|September 17, 2004
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomideClara Montagut, Francesc Bosch, Luís Villela, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
Gene expression profiling in chronic lymphocytic leukaemiaCarles Codony, Marta Crespo, Pau Abrisqueta, et al.
Gastroenterologia Y Hepatologia|April 19, 2015
[Importance of hepatitis B virus screening in hematological patients]Mar Riveiro-Barciela, Gonzalo Artaza, Pau Abrisqueta, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 4, 2019
Acquired von Willebrand syndrome in a patient with small lymphocytic lymphoma and Sjögren's syndrome: which associated condition should be prioritized?José Pardos-Gea, Fernanda Martínez, Pau Abrisqueta, et al.
Experimental Hematology|December 29, 2016
Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effectGuillermo Orti, Pere Barba, Laura Fox, et al.
Haematologica|March 17, 2004
Familial lymphoid neoplasms in patients with mantle cell lymphomaFrederic Tort, Emma Camacho, Francesc Bosch, et al.
Blood|October 6, 2005
How I treat refractory CLLEmili Montserrat, Carol Moreno, Jordi Esteve, et al.
Oncotarget|December 30, 2014
Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivoNoelia Purroy, Pau Abrisqueta, Júlia Carabia, et al.
Haematologica|December 16, 2017
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvementSabela Bobillo, Pau Abrisqueta, Cecilia Carpio, et al.
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Pageof 17